These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Harms, benefits, and the nature of interventions in pragmatic clinical trials. Ali J; Andrews JE; Somkin CP; Rabinovich CE Clin Trials; 2015 Oct; 12(5):467-75. PubMed ID: 26374680 [TBL] [Abstract][Full Text] [Related]
3. Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol. Taljaard M; Weijer C; Grimshaw JM; Ali A; Brehaut JC; Campbell MK; Carroll K; Edwards S; Eldridge S; Forrest CB; Giraudeau B; Goldstein CE; Graham ID; Hemming K; Hey SP; Horn AR; Jairath V; Klassen TP; London AJ; Marlin S; Marshall JC; McIntyre L; McKenzie JE; Nicholls SG; Alison Paprica P; Zwarenstein M; Fergusson DA Trials; 2018 Sep; 19(1):525. PubMed ID: 30261933 [TBL] [Abstract][Full Text] [Related]
4. Gatekeepers for pragmatic clinical trials. Whicher DM; Miller JE; Dunham KM; Joffe S Clin Trials; 2015 Oct; 12(5):442-8. PubMed ID: 26374683 [TBL] [Abstract][Full Text] [Related]
5. Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials. Lantos JD; Wendler D; Septimus E; Wahba S; Madigan R; Bliss G Clin Trials; 2015 Oct; 12(5):485-93. PubMed ID: 26374686 [TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal. Soll RF; Ovelman C; McGuire W Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834 [TBL] [Abstract][Full Text] [Related]
7. Exploring the ethical and regulatory issues in pragmatic clinical trials. Califf RM; Sugarman J Clin Trials; 2015 Oct; 12(5):436-41. PubMed ID: 26374676 [TBL] [Abstract][Full Text] [Related]
8. The Food and Drug Administration and pragmatic clinical trials of marketed medical products. Anderson ML; Griffin J; Goldkind SF; Zeitler EP; Wing L; Al-Khatib SM; Sherman RE Clin Trials; 2015 Oct; 12(5):511-9. PubMed ID: 26374684 [TBL] [Abstract][Full Text] [Related]
10. Harmonization and streamlining of research oversight for pragmatic clinical trials. O'Rourke PP; Carrithers J; Patrick-Lake B; Rice TW; Corsmo J; Hart R; Drezner MK; Lantos JD Clin Trials; 2015 Oct; 12(5):449-56. PubMed ID: 26374678 [TBL] [Abstract][Full Text] [Related]
11. American Society of Clinical Oncology policy statement: oversight of clinical research. American Society of Clinical Oncology J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281 [TBL] [Abstract][Full Text] [Related]
13. The ethical challenges raised in the design and conduct of pragmatic trials: an interview study with key stakeholders. Nicholls SG; Carroll K; Zwarenstein M; Brehaut JC; Weijer C; Hey SP; Goldstein CE; Graham ID; Grimshaw JM; McKenzie JE; Fergusson DA; Taljaard M; Trials; 2019 Dec; 20(1):765. PubMed ID: 31870433 [TBL] [Abstract][Full Text] [Related]
14. An Argument for Fewer Clinical Trials. Borgerson K Hastings Cent Rep; 2016 Nov; 46(6):25-35. PubMed ID: 27711966 [TBL] [Abstract][Full Text] [Related]
15. Ethical issues during the conduct of clinical trials. Silverman H Proc Am Thorac Soc; 2007 May; 4(2):180-4; discussion 184. PubMed ID: 17494728 [TBL] [Abstract][Full Text] [Related]
16. Research ethics and the ethics of research: should we offer clinical trial participation or clinical research partnership to oncology patients in the new millennium? Sampson H Cancer Treat Res; 2008; 140():215-34. PubMed ID: 18283778 [No Abstract] [Full Text] [Related]
17. The Social Value of Pragmatic Trials. Kalkman S; van Thiel G; van der Graaf R; Zuidgeest M; Goetz I; Grobbee D; van Delden J Bioethics; 2017 Feb; 31(2):136-143. PubMed ID: 28060433 [TBL] [Abstract][Full Text] [Related]
18. Use of altered informed consent in pragmatic clinical research. McKinney RE; Beskow LM; Ford DE; Lantos JD; McCall J; Patrick-Lake B; Pletcher MJ; Rath B; Schmidt H; Weinfurt K Clin Trials; 2015 Oct; 12(5):494-502. PubMed ID: 26374677 [TBL] [Abstract][Full Text] [Related]
19. Streamlining the institutional review board process in pragmatic randomized clinical trials: challenges and lessons learned from the Aspirin Dosing: A Patient-centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) trial. Marquis-Gravel G; Robertson H; Jones WS; Riley D; Ford DE; Crenshaw D; Joosten YA; Rudov L; Hernandez AF; Hess R Trials; 2021 Jan; 22(1):90. PubMed ID: 33494785 [TBL] [Abstract][Full Text] [Related]